Association of plasma osteopontin levels with coronary calcification evaluated by tomographic coronary calcium scoring

Journal of Bone and Mineral Metabolism

Volumn 27, Issue 5, 2009, Pages 591-597

  Aryan, Muhammedullah ^a   Kepez, Alper ^b   Atalar, Enver ^a   Hazirolan, Tuncay ^a   Haznedaroglu, Ibrahim ^a   Akata, Deniz ^a   Ozer, Necla ^a   Aksoyek, Serdar ^a   Ovunc, Kanan ^a   Ozmen, Ferhan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Eskisehir Yunus Emre State Hospital   (Turkey)

Author keywords

Coronary atherosclerosis; Coronary calcification; Osteopontin

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OSTEOPONTIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM;

ANTICHOLESTEREMIC AGENTS; CALCINOSIS; CALCIUM; CARDIOMYOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPONTIN; RENIN-ANGIOTENSIN SYSTEM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 68949191218     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-009-0078-2     Document Type: Article

References (37)

1. TM Doherty RC Detrano 1994 Coronary arterial calcification as an active process. A new perspective on an old problem Calcif Tissue Int 54 224 230
2. B Uretsky R Rifkin S Sharma PS Reddy 1998 Value of fluoroscopy in the detection of coronary stenosis: influence of age, sex and number of vessels calcified on diagnostic efficacy Am Heart J 115 232 233
3. PC Keelan LF Bielak K Ashai LS Jamjoum AE Denktas JA Rumberger PF Sheedy II PA Peyser RS Schwartz 2001 Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography Circulation 104 412 417
4. R Wayhs A Zelinger P Raggi 2002 High coronary artery calcium scores pose an extremely elevated risk for hard events J Am Coll Cardiol 39 225 230
5. M Abedin Y Tintut LL Demer 2004 Vascular calcification: mechanisms and clinical ramifications Arterioscler Thromb Vasc Biol 24 1161 1170
6. CM Giachelli SM Schwartz L Liaw 1995 Molecular and cellular biology of osteopontin: potential role in cardiovascular disease Trends Cardiovasc Med 5 88 95
7. SA Steitz MY Speer MD McKee L Liaw M Almedia H Yang CM Giachelli 2002 Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification Am J Pathol 161 2035 2046
8. CM Giachelli MY Speer X Li RM Rajachar H Yang 2005 Regulation of vascular calcification: roles of phosphate and osteopontin Circ Res 15 717 722
9. DT Denhardt M Noda AW O'Regan D Pavlin JS Berman 2001 Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodelling, and cell survival J Clin Invest 21 1998 2003
10. S Hirota M Imakita K Kohri A Ito E Morii S Adachi HM Kim Y Kitamura C Yutani S Nomura 1993 Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: a possible association with calcification Am J Pathol 143 1003 1008
11. CM Giachelli N Bae M Almeida 1993 Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques J Clin Invest 92 1686 1696
12. LA Fitzpatrick A Severson WD Edwards RT Ingram 1994 Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis J Clin Invest 94 1597 1604
13. HM Kwon BK Hong TS Kang K Kwon HK Kim Y Jang D Choi HY Park SM Kang SY Cho HS Kim 2000 Expression of osteopontin in calcified coronary atherosclerotic plaques J Korean Med Sci 15 485 493
14. R Ohmori Y Momiyama H Taniguchi R Takahashi M Kusuhara H Nakamura F Ohsuzu 2003 Plasma osteopontin levels are associated with the presence and extent of coronary artery disease Atherosclerosis 170 333 337
15. P Greenland RO Bonow BH Brundage MJ Budoff MJ Eisenberg 2007 ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) Circulation 115 402 426
16. M Takemoto M Kitahara K Yakote S Asaumi A Take Y Saito S Mari 2001 NK-104, a 3-hydroxy-4-methilglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells Br J Pharmacol 133 83 88
17. N Tanaka Y Momiyama R Ohmori S Sawada M Kusuhara H Nakamura F Ohsuzu 2006 Effect of atorvastatin on plasma osteopontin levels in patients with hypercholesterolemia Arterioscler Thromb Vasc Biol 26 e129 e130
18. Kadoglou NP, Gerasimidis T, Moumtzouoglou A, Kapelouzou A, Sailer N, Fotiadis G, Vitta J, Katinios A, Kougias P, Bandios S, Voliotis K, Karayannacos PE, Liapis CD (2008) Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis. Eur J Vasc Endovasc Surg 35:661-668
19. J Irita T Okura S Manabe M Kurata K Miyoshi S Watanabe T Fukuoka J Higaki 2006 Plasma osteopontin levels are higher in patients with primary aldosteronism than in patients with essential hypertension Am J Hypertens 19 293 297
20. M Kurata T Okura S Watanabe T Fukuoka J Higaki 2006 Osteopontin and carotid atherosclerosis in patients with essential hypertension Clin Sci 11 319 324
21. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R(1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827-832
22. M Mazzali T Kipari V Ophascharoensuk JA Wesson R Johnson J Hughes 2002 Osteopontin: a molecule for all seasons Q J Med 95 3 13
23. P Minoretti C Falcone M Calcagnino E Emanuele MP Buzzi E Coen D Geroldi 2006 Prognostic significance of plasma osteopontin levels in patients with chronic stable angina Eur Heart J 27 802 807
24. Coskun S, Atalar E, Ozturk E, Yavuz B, Ozer N, Goker H, Ovunc K, Aksöyek S, Kes S, Sivri B, Kirazli S, Ozmen F (2006) Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes. J Natl Med Assoc 98:1746-1750
25. T Wada MD McKee S Steitz CM Giachelli 1999 Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin Circ Res 84 166 178
26. Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, Shankland SJ, Alpers CE, Bennett WM, Couser WG (1995) Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196
27. XQ Yu LL Wu XR Huang N Yang RE Gilbert ME Cooper RJ Johnson KN Lai HY Lan 2000 Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II Kidney Int 58 1469 1480
28. Li C, Yang CW, Park CW, Ahn HJ, Kim WY, Yoon KH, Suh SH, Lim SW, Cha JH, Kim YS, Kim J, Chang YS, Bang BK (2003) Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats. Kidney Int 63:454-463
29. Trueblood NA, Xie Z, Communal C, Sam F, Ngoy S, Liaw L, Jenkins AW, Wang J, Sawyer DB, Bing OH, Apstein CS, Colucci WS, Singh K (2001) Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res 88:1080-1087
30. T Kusuyama M Yoshiyama T Omura D Nishiya S Enomoto R Matsumoto Y Izumi K Akioka K Takeuchi H Iwao J Yoshikawa 2005 Angiotensin blockade inhibits osteopontin expression in non-infarcted myocardium after myocardial infarction J Pharmacol Sci 98 283 289
31. R Rocha AE Rudolph GE Frierdich DA Nachowiak BK Kekec EA Blomme EG McMahon JA Delyani 2002 Aldosterone induces a vascular inflammatory phenotype in the rat heart Am J Physiol Heart Circ Physiol 283 H1802 H1810
32. T Sugiyama T Yoshimoto Y Hirono N Suzuki M Sakurada K Tsuchiya I Minami F Iwashima H Sakai T Tateno Y Hirata 2005 Aldosterone increases osteopontin gene expression in rat endothelial cells Biochem Biophys Res Commun 336 163 167
33. Achenbach S, Ropers D, Pohle K, Leber A, Thilo C, Knez A, Menendez T, Maeffert R, Kusus M, Regenfus M, Bickel A, Haberl R, Steinbeck G, Moshage W, Daniel WG (2002) Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation 106:1077-1082
34. TQ Callister P Raggi B Cooil NJ Lippolis DJ Russo 1998 Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography N Engl J Med 339 1972 1978
35. IZ Jaffe ME Mendelsohn 2005 Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells Circ Res 96 643 650
36. 3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci USA 94:9308-9313
37. R Kato Y Momiyama R Ohmori N Tanaka H Taniguchi K Arakawa H Nakamura F Ohsuzu 2009 Prognostic significance of plasma osteopontin levels in patients undergoing percutaneous coronary intervention Circ J 73 152 157